Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis

NCT00552461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Alveolar Proteinosis
Primary Disease

Interventions

DRUG: rituximab

Sponsor

East Carolina University

Collaborators

[object Object]